Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer’s disease diagnosis within 17 years
Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years Fuente: https://www.alz.org/ Léon Beyer,Hannah Stocker,Dan Rujescu,Bernd Holleczek,Julia Stockmann,Andreas Nabers,Hermann Brenner,Klaus Gerwert Abstract Introduction Blood-based biomarkers for Alzheimer's disease (AD) are urgently needed. Here, four...
Read more
